Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Peschanski

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Medecine Sciences : M/S|April 15, 2008
[Stem cells, time for scale-up]Marc Peschanski
Medecine Sciences : M/S|December 13, 2021
Marc Peschanski
Frontiers in Cellular Neuroscience|August 30, 2013
Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesisAlexandra Benchoua, Marc Peschanski
Medecine Sciences : M/S|January 10, 2019
[The time has come of a therapeutic (re)positioning of the ultra-rare diseases]Cécile Martinat, Marc Peschanski
Cell Stem Cell|August 7, 2012
How can human pluripotent stem cells help decipher and cure Huntington's disease?Anselme Perrier, Marc Peschanski
The Lancet. Neurology|July 10, 2003
Cell therapy for Huntington's disease, the next step forwardMarc Peschanski, Steve B Dunnett
Organogenesis|October 2, 2009
Organotypic heart slices for cell transplantation and physiological studiesWalter Habeler, Marc Peschanski, Christelle Monville
Biochemical Society Transactions|July 28, 2010
Human pluripotent stem cells in drug discovery and predictive toxicologyDelphine Laustriat, Jacqueline Gide, Marc Peschanski
Biochemical Society Transactions|November 23, 2011
In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeriaXavier Nissan, Sophie Blondel, Marc Peschanski
Brain : a Journal of Neurology|January 8, 2019
Reply: Could weight loss contribute to the improved mobility with metformin in patients with myotonic dystrophy type 1?Guillaume Bassez, Etienne Audureau, Marc Peschanski
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Medecine Sciences : M/S|April 15, 2008
[Stem cells, time for scale-up]Marc Peschanski
Medecine Sciences : M/S|December 13, 2021
Marc Peschanski
Frontiers in Cellular Neuroscience|August 30, 2013
Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesisAlexandra Benchoua, Marc Peschanski
Medecine Sciences : M/S|January 10, 2019
[The time has come of a therapeutic (re)positioning of the ultra-rare diseases]Cécile Martinat, Marc Peschanski
Cell Stem Cell|August 7, 2012
How can human pluripotent stem cells help decipher and cure Huntington's disease?Anselme Perrier, Marc Peschanski
The Lancet. Neurology|July 10, 2003
Cell therapy for Huntington's disease, the next step forwardMarc Peschanski, Steve B Dunnett
Organogenesis|October 2, 2009
Organotypic heart slices for cell transplantation and physiological studiesWalter Habeler, Marc Peschanski, Christelle Monville
Biochemical Society Transactions|July 28, 2010
Human pluripotent stem cells in drug discovery and predictive toxicologyDelphine Laustriat, Jacqueline Gide, Marc Peschanski
Biochemical Society Transactions|November 23, 2011
In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeriaXavier Nissan, Sophie Blondel, Marc Peschanski
Brain : a Journal of Neurology|January 8, 2019
Reply: Could weight loss contribute to the improved mobility with metformin in patients with myotonic dystrophy type 1?Guillaume Bassez, Etienne Audureau, Marc Peschanski
Pageof 11